|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Maximum power extraction from a partially shaded PV array using shunt-series compensation 显示文摘 | Pooja S Vivek A | 2014 | IEEE Journal of Photovoltaics2014，4，4： | 1 |
| 2 | Phenolic compounds, antioxidant activity and insulinotropic effect of extracts prepared from grape (Vitis vinifera E) byproducts 显示文摘 | Pooja D Pandurang A Kaushik B | 2015 | Journal of Food Science and Technology2015，52，1： | 1 |
| 3 | Contrasr-enhanr-ed nair imaging in the evaluation of inler-tious leptomeningeal diseases显示文摘 | Hernant P Yih-Yian S Pooja A | 2006 | Eur Radiol2006，，58： | 1 |
| 4 | Functionalized goldnanoparticles and their biomedical applications显示文摘 | Pooja M T Komal V Vida A D | 2011 | Nanomaterials2011，1，： | 1 |
| 5 | Role of ethnic variations in TNF-alpha and TNF-beta polymorphisms and risk of breast cancer in India 显示文摘 | Pooja S Francis A Bid HK | 2011 | Breast Cancer Res Treat2011，126，3： | 1 |
| 6 | Past, present and future of rice blast management显示文摘 | Pooja K Katoch A | 2014 | Plant Science Ibday2014，1，3： | 1 |
| 7 | Synthesis of hydrazones derivatives of quinoxalinone prospective antimicrobial and antiinflammatory agents显示文摘 | SUROOR A K POOJA M SHABIR P | 2009 | Acta Poloniae Phamaceu- tica-Drug Research2009，66，2： | 1 |
| 8 | Antimicrobial activity of tryptanthrins in Escherichia coli显示文摘 | POOJA P B KEIR A R VIRALI J P | 2010 | J Med Chem2010，53，9： | 1 |
| 9 | CAG repeat length polymorphism in the androgen receptor gene and breast cancer risk: data on Indian women and survey from the world显示文摘 | RAJENDER S FRANCIS A POOJA S | 2011 | Breast Cancer Res Treat2011，127，3： | 1 |
| 10 | The encapsulation technologyin fruit plants--A review 显示文摘 | Manoj K R Pooja A Shashi K S | 2009 | Biotechnology Advances2009，27，6： | 1 |
| 11 | The effect of pre-irradiation annealing on the thermoluminescence of Li F∶Mg,Cu,P phosphor grown by EFG technique显示文摘 | Pooja S Shruti A Rao S M | 2013 | Radiation Measurements2013，5152，： | 1 |
| 12 | CAG repeat length polymorphism in the androgen receptor gene and breast cancer risk: data on Indian women and survey from the world显示文摘 | Rajender S Francis A Pooja S | 2011 | Breast Cancer Res Treat2011，127，3： | 1 |
| 13 | Design and performance of closed form method for cosine modulated filter bank using different windows functions 显示文摘 | Kumar A Pooja R Singh G K | 2014 | International Journal of Speech Technology2014，17，4： | 1 |
| 14 | Diffuse coronary artery vasospasm in a patient with subarachnoid hemorrhage: A case report显示文摘BACKGROUND Coronary artery vasospasm(CAV)is a reversible,transient form of vasoconstriction with clinical manifestations ranging from stable angina to acute coronary syndromes(ACS).Vasospasm of epicardial coronary arteries or associated micro-vasculature can lead to total or subtotal occlusion and has been demonstrated in nearly 50%of patients undergoing angiography for suspected ACS.The mechanism for CAV has been described in literature,but in a subgroup of patients presenting with intracranial hemorrhage,it appears to be multifactorial.These patients tend to have electrocardiographic changes,elevation of cardiac biomarkers of injury and neurogenic stress cardiomyopathy.CASE SUMMARY A 44-year-old woman presented with severe headaches and tonic-clonic seizures.She was found to have diffuse subarachnoid hemorrhage(SAH)requiring ventricular drain placement,coil embolization and induced hypertension.She subsequently developed chest pain with ST elevations in anterior precordial leads,elevated cardiac enzymes and apical ballooning with left ventricular ejection fraction of 35%on transthoracic echocardiogram.Coronary angiogram revealed severe diffuse triple vessel stenoses secondary to CAV seen distally.Subsequent cardiac MRI notable for apical non-viability and scar formation.CONCLUSION This case highlights a unique etiology of acute myocardial infarction in a patient with SAH leading to ST elevations,diffuse triple vessel CAV and apical scar. | Dennis Grewal Adeba Mohammad Pooja Swamy Islam Abudayyeh Mamas A Mamas Purvi Parwani | 2020 | World Journal of Cardiology2020，12，9： | 0 |
| 15 | An international survey of classification and treatment choices for group D retinoblastoma显示文摘AIM: To determine which IIRC scheme was used by retinoblastoma centers worldwide and the percentage of D eyes treated primarily with enucleation versus globe salvaging therapies as well as to correlate trends in treatment choice to IIRC version used and geographic region.METHODS: An anonymized electronic survey was offered to 115 physicians at 39 retinoblastoma centers worldwide asking about IIRC classification schemes and treatment patterns used between 2008 and 2012. Participants were asked to record which version of the IIRC was used for classification, how many group D eyes were diagnosed, and how many eyes were treated with enucleation versus globe salvaging therapies. Averages of eyes per treatment modality were calculated and stratified by both IIRC version and geographic region. Statistical significance was determined by Chi-square, ANOVA and Kruskal-Wallis tests using Prism.RESULTS: The survey was completed by 29% of physicians invited to participate. Totally 1807 D eyes were diagnosed. Regarding IIRC system, 27% of centers used the Children's Hospital of Los Angeles(CHLA) version, 33% used the Children's Oncology Group(COG) version, 23% used the Philadelphia version, and 17% were unsure. The rate for primary enucleation varied between 0 and 100% and the mean was 29%. By IIRC version, primary enucleation rates were: Philadelphia, 8%; COG, 34%; and CHLA, 37%. By geographic region, primary enucleation rates were: Latin America, 57%; Asia, 40%; Europe, 36%; Africa, 10%, US, 8%; and Middle East, 8%. However, systemic chemoreduction was used more often than enucleation in all regions except Latin America with a mean of 57% per center(P<0.0001). CONCLUSION: Worldwide there is no consensus on which IIRC version is used, systemic chemoreduction was the most frequently used initial treatment during the study period followed by enucleation and primary treatment modality, especially enucleation, varied greatly with regards to IIRC version used and geographic region. | Christina Scelfo Jasmine H Francis Vikas Khetan Thomas Jenkins Brian Marr David H Abramson Carol L Shields Jacob Pe’er Francis Munier Jesse Berry J.William Harbour Andrey Yarovoy Evandro Lucena Timothy G Murray Pooja Bhagia Evelyn Paysse Samuray Tuncer Guillermo L Chantada Annette C Moll Tatiana Ushakova David A Plager Islamov Ziyovuddin Carlos A Leal Miguel A Materin Xun-Da Ji Jose W Cursino Rodrigo Polania Hayyam Kiratli Charlotta All-Ericsson Rejin Kebudi Santosh G Honavar Vicktoria Vishnevskia-Dai Sidnel Epelman Anthony B Daniels Jeanie D Ling Fousseyni Traore Marco A Ramirez-Ortiz | 2017 | International Journal of Ophthalmology(English edition)2017，10，6： | 0 |
| 16 | Mapping COVID-19 in India:Southern states at the forefront of new JN.1 variant显示文摘A new variant,JN.1,stemming from the omicron subvariant BA.2.86,garnered the attention of the World Health Organization(WHO)as a'variant of interest.'Despite its rapid global spread,especially in the US,Canada,France,Singapore,Sweden[1],and the UK,JN.1 is considered to pose minimal danger.Current vaccinations are believed to remain effective against it.The WHO underscores the importance of maintaining immunization records amid co-occurring respiratory illnesses,and epidemiologists recommend monitoring hospitalizations,particularly in areas with low vaccination rates. | Rabin Debnath Arshdeep Singh Kushal Seni Anjali Sharma Viney Chawla Pooja A Chawla | 2024 | Asian Pacific Journal of Tropical Medicine2024，17，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员